Trial Outcomes & Findings for Community Servings: Food as Medicine for Diabetes (NCT NCT02426138)
NCT ID: NCT02426138
Last Updated: 2019-10-30
Results Overview
Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality The score is an average of the three-time periods that data was collected
COMPLETED
NA
44 participants
Average of 3 24-hour food recalls per study period (on and off meals; one in-person visit and 2 over the phone at 4 and 8 weeks into the study)
2019-10-30
Participant Flow
Participant milestones
| Measure |
Meal Delivery Then Usual Care + Choose myPlate
During the first intervention period, participants in this arm will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the first intervention period will comprise the 'on-meal' data for this participants in this arm.
Following this, during the second intervention period, they will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the second intervention period will comprise the 'off-meal' data for participants in this arm.
|
Usual Care + Choose myPlate Then Meal Delivery
During the first intervention period, participants in this arm will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the first intervention period will comprise the 'off-meal' data for participants in this arm.
Following this, during the second intervention period, participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the second intervention period will comprise the 'on-meal' data for this participants in this arm.
|
|---|---|---|
|
First Intervention (12 Weeks)
STARTED
|
21
|
23
|
|
First Intervention (12 Weeks)
COMPLETED
|
20
|
22
|
|
First Intervention (12 Weeks)
NOT COMPLETED
|
1
|
1
|
|
Second Intervention (12 Weeks)
STARTED
|
20
|
22
|
|
Second Intervention (12 Weeks)
COMPLETED
|
20
|
22
|
|
Second Intervention (12 Weeks)
NOT COMPLETED
|
0
|
0
|
|
Intent to Treat Population Milestone
STARTED
|
20
|
22
|
|
Intent to Treat Population Milestone
COMPLETED
|
20
|
22
|
|
Intent to Treat Population Milestone
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
| Measure |
Meal Delivery Then Usual Care + Choose myPlate
During the first intervention period, participants in this arm will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the first intervention period will comprise the 'on-meal' data for this participants in this arm.
Following this, during the second intervention period, they will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the second intervention period will comprise the 'off-meal' data for participants in this arm.
|
Usual Care + Choose myPlate Then Meal Delivery
During the first intervention period, participants in this arm will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the first intervention period will comprise the 'off-meal' data for participants in this arm.
Following this, during the second intervention period, participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the second intervention period will comprise the 'on-meal' data for this participants in this arm.
|
|---|---|---|
|
First Intervention (12 Weeks)
Withdrawal by Subject
|
1
|
1
|
Baseline Characteristics
Community Servings: Food as Medicine for Diabetes
Baseline characteristics by cohort
| Measure |
Meal Delivery Then Usual Care + Choose myPlate
n=20 Participants
During the first intervention period, participants in this arm will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the first intervention period will comprise the 'on-meal' data for this participants in this arm.
Following this, during the second intervention period, they will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the second intervention period will comprise the 'off-meal' data for participants in this arm.
|
Usual Care + Choose myPlate Then Meal Delivery
n=22 Participants
During the first intervention period, participants in this arm will receive 12 weeks of usual diabetes care + a Choose MyPlate healthy eating brochure, without meal delivery. Data recorded during or at the end of the first intervention period will comprise the 'off-meal' data for participants in this arm.
Following this, during the second intervention period, participants will receive 12 weeks of medically tailored meal delivery, comprising approximately half of their weekly caloric intake and consisting of foods prepared under the supervision of a registered dietitian to be compatible with a diabetes diet. They will also receive usual diabetes care and a Choose MyPlate healthy eating brochure. Data recorded during or at the end of the second intervention period will comprise the 'on-meal' data for this participants in this arm.
|
Total
n=42 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
57.66 years
STANDARD_DEVIATION 12.25 • n=99 Participants
|
59.21 years
STANDARD_DEVIATION 13.11 • n=107 Participants
|
58.5 years
STANDARD_DEVIATION 12.6 • n=206 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=99 Participants
|
16 Participants
n=107 Participants
|
29 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=99 Participants
|
6 Participants
n=107 Participants
|
13 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic White
|
10 Participants
n=99 Participants
|
13 Participants
n=107 Participants
|
23 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic Black
|
5 Participants
n=99 Participants
|
6 Participants
n=107 Participants
|
11 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
4 Participants
n=99 Participants
|
3 Participants
n=107 Participants
|
7 Participants
n=206 Participants
|
|
Race/Ethnicity, Customized
Other
|
1 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
20 participants
n=99 Participants
|
22 participants
n=107 Participants
|
42 participants
n=206 Participants
|
|
Healthy Eating Index 2010 Score
|
57.27 units on a scale
STANDARD_DEVIATION 14.65 • n=99 Participants
|
57.16 units on a scale
STANDARD_DEVIATION 13.49 • n=107 Participants
|
57.21 units on a scale
STANDARD_DEVIATION 14.04 • n=206 Participants
|
PRIMARY outcome
Timeframe: Average of 3 24-hour food recalls per study period (on and off meals; one in-person visit and 2 over the phone at 4 and 8 weeks into the study)Population: ITT
Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality The score is an average of the three-time periods that data was collected
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Healthy Eating Index 2010 Score
|
71.30 units on a scale
Standard Deviation 7.49
|
39.89 units on a scale
Standard Deviation 7.80
|
SECONDARY outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Food insecurity is defined as \> 2 affirmative responses on the 10 adult referenced items USDA Household Food Security Survey Module
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Number of Participants With Food Insecurity
|
13 Participants
|
24 Participants
|
SECONDARY outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Diabetes Distress calculated using the Diabetes Distress Scale Minimum and Maximum scores range of the scale is 17-106 For this measure the lower the score the better
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=34 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Diabetes Distress Scale
|
30.94 units on a scale
Standard Deviation 13.77
|
30.82 units on a scale
Standard Deviation 10.70
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
This will be measured using a fasting blood draw at baseline, 12 and 24 weeks
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Hemoglobin A1c
|
7.99 % of hemoglobin
Standard Deviation 1.86
|
8.15 % of hemoglobin
Standard Deviation 1.72
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
A fasting blood draw will be used to measure: LDL Cholesterol
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
LDL Cholesterol
|
97.54 mg/dl
Standard Deviation 35.67
|
101.43 mg/dl
Standard Deviation 43.11
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Body Mass Index will be measured in light street clothes (without shoes) using a single calibrated scale. Height measured using a stadiometer. Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters. A high BMI can be an indicator of high body fatness.
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Body Mass Index
|
34.24 kg/m^2
Standard Deviation 6.76
|
34.79 kg/m^2
Standard Deviation 6.97
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometerPopulation: ITT
Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Systolic Blood Pressure
|
133.04 mm hg
Standard Deviation 17.60
|
136.00 mm hg
Standard Deviation 18.77
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometerPopulation: ITT
Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Diastolic Blood Pressure
|
76.86 mm hg
Standard Deviation 8.65
|
78.16 mm hg
Standard Deviation 10.11
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Change from baseline in Medication Adherence Rating Scale (Assessed using medication adherence rating scale) Range is 0-25 The higher the number the better
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Change From Baseline in Medication Adherence
|
23.19 units on a scale
Standard Deviation 2.86
|
22.28 units on a scale
Standard Deviation 3.21
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Cost Related Medication Under-use (Defined as \> 0 affirmative responses to 4-items on cost-related medication under-use from the medication expenditure panel survey)
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Number of Participants With Cost Related Medication Under-Use
|
7 Participants
|
11 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Prevalence of food and medication trade-offs between groups
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Number of Participants With Food and Medication Trade-offs
|
9 Participants
|
9 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Patient Health Questionnaire - 8 item version. The score ranges 0-24, The lower score represents less depressive symptoms
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Depressive Symptoms (Assessed Using the PHQ-8 Scale)
|
6.16 units on a scale
Standard Deviation 5.15
|
6.13 units on a scale
Standard Deviation 4.96
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: This outcome was planned to be measured but not measured owing to technical difficulties in assessment
This outcome was planned to be measured but not measured owing to technical difficulties in assessment
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participantPopulation: ITT
Report of hypoglycemia requiring assistance in last 3 months
Outcome measures
| Measure |
On Meals
n=30 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=36 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Number of Participants With Self-reported Hypoglycemia
|
14 Participants
|
23 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood drawPopulation: ITT
A fasting blood draw will be used to measure: Triglycerides
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Triglycerides
|
142.00 mg/dl
Interval 83.0 to 258.0
|
127.50 mg/dl
Interval 99.5 to 175.5
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood drawPopulation: ITT
A fasting blood draw will be used to measure: HDL Cholesterol
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
HDL Cholesterol
|
45.81 mg/dl
Standard Deviation 11.23
|
46.36 mg/dl
Standard Deviation 10.20
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood drawPopulation: ITT
A fasting blood draw will be used to measure: Total Cholesterol
Outcome measures
| Measure |
On Meals
n=31 Participants
Outcome recorded while receiving medically tailored meals
|
Off Meals
n=39 Participants
Outcome recorded while not receiving meals
|
|---|---|---|
|
Total Cholesterol
|
182.63 mg/dl
Standard Deviation 47.30
|
178.69 mg/dl
Standard Deviation 43.82
|
Adverse Events
Medically Tailored Meal Delivery
Usual Care + Choose Myplate (Delayed)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Seth A. Berkowitz
University of North Carolina at Chapel Hill
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place